Henry Schein Congratulates Dr. Louis W. Sullivan for Receiving a 2023 National Humanism in Medicine Medal, Awarded by The Arnold P. Gold Foundation

Henry Schein, Inc. (Nasdaq: HSIC) today celebrates Dr. Louis W. Sullivan for receiving a 2023 National Humanism in Medicine Medal from The Arnold P. Gold Foundation. Co-Chair of the Henry Schein Cares Foundation since 2008 and a former member of Henry Schein’s Board of Directors for 13 years, Dr. Sullivan was one of four health care leaders honored by The Gold Foundation for his lifetime of leadership and for championing human values and dignity as the core of health care practice.

Medal recipients were recognized during The Gold Foundation’s Annual Gala held at the Ziegfeld Ballroom in New York City on June 20, 2023. In addition to Dr. Sullivan, honorees included: Dr. Gina S. Brown, Dean of the College of Nursing and Allied Health Sciences at Howard University; Dr. Richard I. Levin, President and CEO of The Gold Foundation; and Dr. Eileen Sullivan-Marx, Dean of the NYU Rory Meyers College of Nursing.

“Dr. Sullivan has spent more than six decades championing humanism in health care and pursuing health equity and better health care for all,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein. “For more than 16 years, we’ve been privileged to advance health equity and empower health care professionals through our work together at Henry Schein and the Henry Schein Cares Foundation. As an incredible advocate and leader in promoting diversity in the health care workforce, Dr. Sullivan has helped improve the lives of countless individuals and communities. We pay tribute to Dr. Sullivan and all the honorees for their passionate dedication to advancing human dignity, health and well-being, and are so pleased to celebrate this most meaningful recognition.”

A lifelong health equity advocate and renowned leader in health policy, Dr. Sullivan served as Secretary of the U.S. Department of Health and Human Services under President George H. W. Bush. He is the Founding Dean and President of Morehouse School of Medicine, and is Chairman of the Washington, D.C.-based Sullivan Alliance to Transform the Health Professions, which is now a central program of the Association of Academic Health Centers (AAHC). In 2022, the AAHC merged into the Association of American Medical Colleges.

“We are honored to recognize Dr. Sullivan and all of the distinguished leaders who have each made an indelible mark on humanism in health care,” said Gold Foundation Board Chairman Richard C. Sheerr. “Their pioneering vision and immense dedication – across nursing and medical schools, innovative public policy and community health, nationally and globally – has made a remarkable difference to patient care.”

Henry Schein has been a long-time partner of The Gold Foundation, supporting the organization’s commitment to nurturing humanism in health care and the needs of health care professionals who improve health outcomes. Henry Schein co-founded The Gold Foundation’s Corporate Council in 2017, and Allison Neale, Henry Schein’s Vice President of Public Policy and Managing Director of the Henry Schein Cares Foundation, serves as the Council’s Chair. The Gold Corporate Council harnesses the power of diverse companies within the health care sector to advance humanism within the broader health care ecosystem, with other members including BD, CVS Health, Medallia, Quest Diagnostics, and Siemens Healthineers.

For more information about The Gold Foundation’s Annual Gala and its honorees, visit https://www.gold-foundation.org/2023gala/.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”